AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie cash Dividends Declared ($M) ($M)
Form 10-Q / 10-K Consolidated Statements of Stockholders' Equity & Cash Flows
Latest, FY2025
11,819
Period ended Dec 31, 2025
Change on a year earlier
+5.7%
11,178 in FY2024
History
11 years
Since FY2015
Sources
9
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cash Dividends Declared ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11,819 | +5.7% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 11,178 | +5.0% | Form 10-K (filed 2026-02-20) ↗ |
| FY2023 | Dec 31, 2023 | 10,647 | +4.6% | Form 10-K (filed 2026-02-20) ↗ |
| FY2022 | Dec 31, 2022 | 10,179 | +7.5% | Form 10-K (filed 2025-02-14) ↗ |
| FY2021 | Dec 31, 2021 | 9,470 | +14.4% | Form 10-K (filed 2024-02-20) ↗ |
| FY2020 | Dec 31, 2020 | 8,278 | +26.7% | Form 10-K (filed 2023-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 6,533 | +8.1% | Form 10-K (filed 2022-02-18) ↗ |
| FY2018 | Dec 31, 2018 | 6,045 | +43.2% | Form 10-K (filed 2021-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 4,221 | +10.4% | Form 10-K (filed 2020-02-21) ↗ |
| FY2016 | Dec 31, 2016 | 3,823 | +11.4% | Form 10-K (filed 2019-02-27) ↗ |
| FY2015 | Dec 31, 2015 | 3,431 | – | Form 10-K (filed 2018-02-16) ↗ |
Breakdown
What makes up cash dividends declared ($m)
- Dividends Declared per Common Share ($/sh)6.65 · FY2025
- Cash Paid for Purchases of Common Stock ($M)980 · FY2025
- Common Stock Held in Treasury (M shares)70.80 · FY2025
- Treasury Stock Carrying Value ($M)9,146 · FY2025
- Stock-Based Compensation Expense ($M)955 · FY2025
- Stock-Based Compensation Tax Benefit ($M)170 · FY2025
Cite this data
StockData. (2026). AbbVie Cash Dividends Declared ($M) ($M), annual FY2015–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/cap_div_decl
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.